Role of Interleukin-10 in a Murine Model of Dextran Sulfate Sodium-Induced Colitis

REFERENCES

• Fiocchi C. Cytokines. In: MacDermott R, Stenson W, editors. Inflammatory bowel diseases. New York: Elsevier; 1992. p. 137–62.
   Google Scholar
• Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533–9.
   PubMed Web of Science ®Google Scholar
• Reinecker H-C, Schreiber S, Stenson WF, MacDermott RP. The role of the mucosal immune system in ulcerative colitis and Crohn’s disease. In: Ogra PL, StroberW, Mestecky J, McGhee JR, Lamm ME, Bienenstock J, editors. Handbook of mucosal immunology: San Diego (CA): Academic Press; 1994. p. 439–56.
   Google Scholar
• Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587–95.
   Google Scholar
• Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, et al. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818–26.
   PubMed Web of Science ®Google Scholar
• Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1β by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn’s disease. Gut 1989; 30:835–8.
   Google Scholar
• MacDonald TT, Hutchings P, Choy M-Y, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301–5.
   Google Scholar
• Mitsuyama K, Sasaki E, Toyonaga A, Ikeda H, Tsuruta O, Irie A, et al. Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 1991;50:104–11.
   PubMed Web of Science ®Google Scholar
• Mitsuyama K, Toyonaga A, Sasaki E, Watanabe H, Tateishi H, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1994;96:432–6.
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Mitsuyama K, Toyonaga A, Sasaki E, Tanikawa K. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel diseae. Digestion 1994;55: 368–73.
   Google Scholar
• van Dullemen HM, van Devenrter SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, et al. Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129–35.
   PubMed Web of Science ®Google Scholar
• Schreiber S, Heinig T, Thiele H-G, Raedler A. Immunoregulatory role of interleukin 10 in patient with inflammatory bowel disease. Gastroenterology 1995;108: 1434–44
   Google Scholar
• Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170: 2081–95.
   Google Scholar
• Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147: 3815–22.
   Google Scholar
• de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–20.
   PubMed Web of Science ®Google Scholar
• Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-α and interleukin-10. J Biol Chem 1992;267:23301–8.
   PubMed Web of Science ®Google Scholar
• Howard M, O’Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198–200.
   PubMedGoogle Scholar
• Kuhn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263–74.
   PubMed Web of Science ®Google Scholar
• Herfarth HH, Mohanty SP, Tonkonoogy S, Sartor RB. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996;39:836–45.
   PubMed Web of Science ®Google Scholar
• Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the Induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694–702.
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643–52.
   PubMed Web of Science ®Google Scholar
• Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344–50.
   Google Scholar
• Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 1993;151:6853–61.
   PubMed Web of Science ®Google Scholar
• Kojouharoff G, Hans W, Obermeier F, Schölmerich J, Andus T, Männel DN, et al. Reduction of inflammatory score by neutralization of tumor necrosis factor alpha (TNF) and not interleukin-1 (IL-1) in experimental dextrane sulfate (DSS-) induced chronic colitis. Gastroenterology 1996;110:A940.
   Google Scholar
• Neurath MF, Kollias G, Duchamann R, Fuss I, Strober W, zum Buschenfelde KHM. Effects of antibodies to TNFα on acute and chronic experimental colitis in mice. Gastroenterology 1996; 110:A979.
   Google Scholar
• Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992;103:65–71.
   PubMed Web of Science ®Google Scholar
• Thomas TK, Will PC, Srivastava A, Wilson CL, Harbison M, Little J, et al. Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model. Agents Actions 1991;34:187–90.
   PubMedGoogle Scholar
• McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 1994;106:960–72.
   PubMed Web of Science ®Google Scholar
• Tateishi H, Mitsuyama K, Toyonaga A, Tomoyose M, Tanikawa K. Role of cytokines in experimental colitis: Relation to intestinal permeability. Digestion 1997;58:271–81.
   PubMed Web of Science ®Google Scholar
• Harada K, Toyonaga A, Mitsuyama K, Sasaki E, Tanikawa K. Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis. Digestion 1994;55: 179–84.
   Google Scholar
• Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177: 547–50.
   Google Scholar
• Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205–8.
   PubMed Web of Science ®Google Scholar
• van Laethem J-L, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995;108: 1917–22.
   Google Scholar
• Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989;86:3803–7.
   PubMed Web of Science ®Google Scholar
• Malefyt RW, Figdor CG, Huijbens R, Peterson SM, Bennett B, Culpepper J, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFNγ or IL-10. J Immunol 1993;151:6370–81.
   Google Scholar
• Attisano L, Wrana JL, Casillas FF, Massagué J. TGF-beta receptor and actions. Biochim Biohys Acta 1994;1222:71–80.
   PubMed Web of Science ®Google Scholar